https://www.selleckchem.com/pr....oducts/necrosulfonam
01) and trended to longer PFS when compared to other consolidation strategies (p=0.06). OS was similarly improved in patients consolidated with ASCT compared with no consolidation (p=0.04), but not compared with other consolidation (p=0.22). Although patients receiving ASCT were younger, KPS, sex, and number of recurrences were similar between consolidation groups. A multivariate analysis confirmed an independent effect of consolidation group on PFS (p=0.01), but not OS. PFS may be a useful surrogate endpoint which predicts OS
Like
Comment
Share
